Contents: Patients

Patients
Patients

Click here

Introduction
Introduction

Welcome from the Editor

Click here

Time for a new model in patient access
Time for a new model in patient access

Mig Sleeper, vice president, Global Pricing for Astellas, explains why we must rethink how value is defined as we enter a new technological era for medicines.

Click here

Emerging from the shadow of COVID-19
Emerging from the shadow of COVID-19

We now have a unique opportunity to re-discover what matters most to patients, says Alnylam’s Kasha Witkos

Click here

The pharma world at your fingertips
The pharma world at your fingertips

Daily and weekly email newsletters from pharmaphorum – insights and analysis on the big trends shaping healthcare and the pharmaceutical industry

Click here

How the combination treatment challenge impacts patients and how we are working together to solve it
How the combination treatment challenge impacts patients and how we are working together to solve it

Access to medicines attracts a great deal of interest from patients, clinicians, and the public and there have been significant advances in drug development in recent years which looks set to continue. Helen Taylor, Programme Realisation Manager for Takeda UK, and Eric Low, Founder of Myeloma UK, discuss the unique challenges around access to combination treatments.

Click here

Patients want to be heard. Is pharma listening?
Patients want to be heard: is pharma listening?

Patients want to be part of the healthcare conversation and genuinely heard by those who make the final decisions, but pharma does not always understand how to connect with patients

Click here

Health literacy for the intellectually disabled: is pharma doing enough?
Health literacy for the intellectually disabled: is pharma doing enough?

Prime Global’s Olivia Kersey asks, What is health literacy and why is it important?

Click here

Three views on technology improving clinical trial efficiency
Three views on technology improving clinical trial efficiency

Marie Emms, vice president of site and patient participation at Syneos Health, tells us technology helped increase patient enrolment, improve diversity and inclusion, and boost retention rates for clinical trials after the pandemic. Still, she says a lot needs to be done to continue this upward trajectory.

Click here

How biomarkers and bioanalytics are changing R and D
How biomarkers and bioanalytics are changing R&D

Biomarkers have been causing a paradigm shift in how HCPs treat patients for some time – now they are bringing the pharma industry a new gold standard for clinical research.

Click here

Leveraging real-world data to meet payers’ needs
Payers are becoming savvier in accepting real-world data

Certara’s Lee Stern and Shawn Bates discuss the challenges and how pharma can use real-world data to meet payers’ needs.

Click here

The pharmaphorum podcast

Download exclusive interviews and discussions with senior pharma and biotech executives

Click here

Time to take patient engagement
Time to take patient engagement to the next level

Patient engagement in pharma is evolving, with some companies doing it better than others. Envision Pharma Group’s Dawn Lobban and Sarah Avent discuss the need to engage with patients at every level for holistic inclusion of the patient voice in order for pharma to become truly patient-centric.

Click here

The booming life sciences sector needs dynamic real estate support

Bruntwood SciTech is the UK’s leading property provider dedicated to driving the growth of the science and technology sector

Click here

Recruiting patients to increase diversity & inclusion in clinical trials
Recruiting patients to increase diversity & inclusion in clinical trials

The inclusion of more diverse, and often more relevant, study populations is gathering momentum within the clinical trial community.

Click here

future editions
Subscribe to future editions of Deep Dive

Sign-up to receive the next issue of pharmaphorum’s digital magazine for pharma direct to your inbox

Click here

contact
Contact the Deep Dive team

How to get in touch with the editorial, commercial and design teams for pharmaphorum’s digital magazine

Click here

Video
Share

Your name

Your e-mail

Name receiver

E-mail address receiver

Your message

Send

Share

E-mail

Facebook

Twitter

LinkedIn

Contact

Send